Uric acid in-hospital changes predict mortality in patients with acute myocardial infarction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 23, Issue 12, 2013, Pages 1202-1209

  Lazaros, G ^a   Tsiachris, D ^a   Aznaouridis, K ^a   Vlachopoulos, C ^a   Tsioufis, C ^a   Chrysohoou, C ^a   Patialiakas, A ^a   Masoura, C ^a   Stefanadis, C ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute myocardial infarction; Mortality; Risk stratification; Uric acid levels

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; FIBRINOLYTIC AGENT; GLUCOSE; HEMOGLOBIN; TROPONIN I; URIC ACID;

ACCURACY; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; COLORIMETRY; DIABETES MELLITUS; FEMALE; GLOMERULUS FILTRATION RATE; HEART EJECTION FRACTION; HOSPITAL; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; RECEIVER OPERATING CHARACTERISTIC; REVASCULARIZATION; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ACUTE MYOCARDIAL INFARCTION; MORTALITY; RISK STRATIFICATION; URIC ACID LEVELS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; FEMALE; HOSPITALIZATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; URIC ACID;

EID: 84888838982     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2013.04.001     Document Type: Article

References (30)

1. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N Engl J Med 2008, 359:1811-1821.
2. Gagliardi A.C., Miname M.H., Santos R.D. Uric acid: a marker of increased cardiovascular risk. Atherosclerosis 2009, 202:11-17.
3. Xaplanteris P., Vlachopoulos C., Vyssoulis G., Terentes-Printzios D., Alexopoulos N., Lazaros G., et al. Uric acid levels, left ventricular mass and geometry in newly diagnosed, never treated hypertension. J Hum Hypertens 2011, 25:340-342.
4. Vlachopoulos C., Xaplanteris P., Vyssoulis G., Bratsas A., Baou K., Tzamou V., et al. Association of serum uric acid level with aortic stiffness and arterial wave reflections in newly diagnosed, never-treated hypertension. Am J Hypertens 2011, 24:33-39.
5. Strazzulo P., Puig J.G. Uric acid and oxidative stress: relative impact on cardiovascular risk?. Nutr Metab Cardiovasc Dis 2007, 17:409-414.
6. Tsioufis C., Kyvelou S., Dimitriadis K., Syrseloudis D., Sideris S., Skiadas I., et al. The diverse associations of uric acid with low-grade inflammation, adiponectin and arterial stiffness in never-treated hypertensives. J Hum Hypertens 2011, 25:554-559.
7. Tsioufis C., Chatzis D., Vezali E., Dimitriadis K., Antoniadis D., Zervoudaki A., et al. The controversial role of serum uric acid in essential hypertension: relationships with indices of target organ damage. J Hum Hypertens 2005, 19:211-217.
8. Santos R.D., Nasir K., Orakzai R., Meneghelo R.S., Carvalho J.A., Blumenthal R.S. Relation of uric acid levels to presence of coronary artery calcium detected by electron beam tomography in men free of symptomatic myocardial ischemia with versus without the metabolic syndrome. Am J Cardiol 2007, 99:42-45.
9. Kocaman S.A., Sahinarslan A., Cemri M., Timurkaynak T., Boyaci B., Cengel A. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden. Nutr Metab Cardiovasc Dis 2009, 19:729-775.
10. Bos M.J., Koudstaal P.J., Hofman A., Witteman J.C., Breteler M.M. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006, 37:1503-1507.
11. Fang J., Alderman M.H. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. J Am Med Assoc 2000, 283:2404-2410.
12. Culleton B.F., Larson M.G., Kannel W.B., Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med 1999, 131:7-13.
13. Silbernagel G., Hoffmann M.M., Grammer T.B., Boehm B.O., März W. Uric acid is predictive of cardiovascular mortality and sudden cardiac death in subjects referred for coronary angiography. Nutr Metab Cardiovasc Dis 2013, 23:46-52.
14. De Luca G., Secco G.G., Santagostino M., Venegoni L., Iorio S., Cassetti E., et al. Uric acid does not affect the prevalence and extent of coronary artery disease. Results from a prospective study. Nutr Metab Cardiovasc Dis 2012, 22:426-433.
15. Kojima S., Sakamoto T., Ishihara M., Kimura K., Miyazaki S., Yamagishi M., et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am J Cardiol 2005, 96:489-495. Japanese Acute Coronary Syndrome Study (JACSS) Investigators.
16. Lazzeri C., Valente S., Chiostri M., Sori A., Bernardo P., Gensini G.F. Uric acid in the acute phase of ST elevation myocardial infarction submitted to primary PCI: its prognostic role and relation with inflammatory markers: a single center experience. Int J Cardiol 2010, 138:206-209.
17. Kaya M.G., Uyarel H., Akpek M., Kalay N., Ergelen M., Ayhan E., et al. Prognostic value of uric acid in patients with ST-elevated myocardial infarction undergoing primary coronary intervention. Am J Cardiol 2012, 109:486-491.
18. Kowalczyk J., Francuz P., Swoboda R., Lenarczyk R., Sredniawa B., Golda A., et al. Prognostic significance of hyperuricemia in patients with different types of renal dysfunction and acute myocardial infarction treated with percutaneous coronary intervention. Nephron Clin Pract 2010, 116:c114-c122.
19. Lazzeri C., Valente S., Chiostri M., Picariello C., Gensini G.F. Uric acid in the early risk stratification of ST-elevation myocardial infarction. Intern Emerg Med 2012, 7:33-39.
20. Levantesi G., Marfisi R.M., Franzosi M.G., Maggioni A.P., Nicolosi G.L., Schweiger C., et al. Uric acid: a cardiovascular risk factor in patients with recent myocardial infarction. Int J Cardiol 2012 Jan 18, [Epub ahead of print].
21. Antman E.M., Hand M., Armstrong P.W., Bates E.R., Green L.A., Halasyamani L.K., et al. 2007 focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction. J Am Coll Cardiol 2008, 51:210-247.
22. Bassand J.P., Hamm C.W., Ardissino D., Boersma E., Budaj A., Fernández-Avilés F., et al. Task force for diagnosis and treatment of non-ST-segment elevation acute coronary syndromes of European Society of Cardiology Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 2007, 13:1598-1660.
23. Levey A.S., Bosch J., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
24. Dosman J.A., Crawhall J.C., Klassen G.A. Uric acid kinetic studies in the immediate post-myocardial-infarction period. Metabolism 1975, 24:473-480.
25. Ejaz A.A., Mu W., Kang D.H., Roncal C., Sautin Y.Y., Henderson G., et al. Could uric acid have a role in acute renal failure?. Clin J Am Soc Nephrol 2007, 2:16-21.
26. Yamamoto T., Moriwaki Y., Takahashi S., Tsutsumi Z., Hada T. Effect of norepinephrine on the urinary excretion of purine bases and oxypurinol. Metabolism 2001, 50:1230-1233.
27. Akpek M., Kaya M.G., Uyarel H., Yarlioglues M., Kalay N., Gunebakmaz O., et al. The association of serum uric acid levels on coronary flow in patients with STEMI undergoing primary PCI. Atherosclerosis 2011, 219:334-341.
28. Basar N., Sen N., Ozcan F., Erden G., Kanat S., Sokmen E., et al. Elevated serum uric acid predicts angiographic impaired reperfusion and 1-year mortality in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention. J Investig Med 2011, 59:931-937.
29. Rentoukas E., Tsarouhas K., Tsitsimpikou C., Lazaros G., Deftereos S., Vavetsi S. The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention. Int J Cardiol 2010, 145:257-258.
30. Simon J.A. Clinical trials of uric acid lowering for coronary heart disease risk reduction. Am J Med 2006, 119:e5.